Michael Zering

Michael Zering, CEO of Apricot Bio, Lucas Pelkmans, a cell biology expert, and oncologist Andreas Wicki discuss groundbreaking advancements in functional precision oncology. They highlight the limitations of traditional genomic diagnostics and propose ex vivo testing of patient-derived cells to enhance treatment decisions. The trio compares real-time cellular data to Google Maps for better navigation through cancer treatment. They also cover the potential of smarter clinical trials and the integration of AI in predicting patient responses, promising a transformative future for cancer care.